2096

COM:SIMCERE

Simcere Pharmaceutical Group

Stock

Last Close

6.85

21/11 08:08

Market Cap

14.37B

Beta: -

Volume Today

3.77M

Avg: -

Overview Analysis Metrics Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue	3.87B -	4.51B 16.71%	5.04B 11.57%	4.51B 10.48%	5.00B 10.89%	6.32B 26.39%	6.61B 4.57%
cost of revenue	586.30M -	771.20M 31.54%	888.49M 15.21%	899.93M 1.29%	1.08B 20.01%	1.32B 22.43%	1.62B 22.80%
gross profit	3.28B -	3.74B 14.06%	4.15B 10.82%	3.61B 13.00%	3.92B 8.62%	5.00B 27.48%	4.98B 0.25%
selling and marketing expenses	2.16B -	2.22B 3.07%	2.02B 9.25%	1.57B 22.11%	2.04B 29.70%	2.40B 17.95%	2.36B 1.91%
general and administrative expenses	126.92M -	129.74M 2.22%	142.60M 9.91%	411.48M 188.55%	382.49M 7.05%	444.20M 16.14%	499.28M 12.40%
selling general and administrative expenses	2.28B -	2.35B 3.02%	2.16B 8.19%	1.98B 8.20%	2.42B 22.07%	2.85B 17.67%	2.85B 0.29%
research and development expenses	212.31M -	447.15M 110.61%	716.41M 60.22%	1.14B 59.40%	1.42B 24.06%	1.73B 21.99%	1.56B 9.55%
other expenses	5.02M -	12.05M 139.85%	132.77M 1,001.79%	-104.94M 179.04%	-132.16M 25.94%	-154.52M 16.92%
cost and expenses	3.17B -	3.67B 16.06%	3.90B 6.03%	3.92B 0.57%	4.78B 22.07%	5.74B 20.04%	5.89B 2.54%
operating expenses	2.58B -	2.90B 12.54%	3.01B 3.59%	3.02B 0.36%	3.70B 22.69%	4.42B 19.35%	4.26B 3.52%
interest expense	58.44M -	47.53M 18.66%	115.95M 143.94%	133.73M 15.33%	70.85M 47.02%	34.41M 51.43%
ebitda	825.49M -	1.02B 23.07%	1.34B 32.17%	787.99M 41.31%	939.71M 19.25%	1.09B 15.88%	940.75M 13.61%
operating income	530.58M -	941.94M 77.53%	1.17B 24.35%	565.66M 51.71%	687.90M 21.61%	862.50M 25.38%	732.44M 15.08%
depreciation and amortization	104.14M -	120.00M 15.23%	171.40M 42.83%	222.33M 29.72%	251.81M 13.26%	226.47M 10.06%	208.32M 8.02%
total other income expenses net	-251.24M -	88.35M 135.16%	-89.50M 201.30%	239.42M 367.53%	713.90M 198.17%	25.65M 96.41%	7.60M 70.37%
income before tax	497.28M -	929.04M 86.82%	1.08B 16.44%	805.09M 25.58%	1.40B 74.12%	888.15M 36.64%	740.04M 16.68%
income tax expense	146.87M -	195.36M 33.01%	78.19M 59.98%	140.80M 80.07%	-97.12M 168.98%	-40.48M 58.32%	26.09M 164.45%
net income	350.41M -	733.69M 109.38%	1.00B 36.79%	669.53M 33.29%	1.51B 125.10%	932.77M 38.11%	714.76M 23.37%
weighted average shs out	2.61B -	2.61B 0%	2.61B 0%	2.61B 0.11%	2.61B 0%	2.61B 0.10%	2.65B 1.38%
weighted average shs out dil	2.61B -	2.61B 0%	2.61B 0%	2.61B 0.11%	2.61B 0.10%	2.62B 0.35%	2.61B 0.45%
eps	0.13 -	0.28 115.38%	0.39 39.29%	0.26 33.33%	0.58 123.08%	0.40 31.03%	0.27 32.50%
epsdiluted	0.13 -	0.28 115.38%	0.39 39.29%	0.26 33.33%	0.58 123.08%	0.40 31.03%	0.27 32.50%

All numbers in (except ratios and percentages)